|
LamisilDrug - Lamisil The trade name of the product as shown on the labeling.
Dosage -
CREAM; TOPICAL
Active Ingredient(s) -
Terbinafine Hydrochloride
Strength -
1%
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
020192
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 30, 1992
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Lamisil
Lamisil 1% Gel; Topical
Lamisil 1% Cream; Topical Terazosin Hcl Eq 2mg Base Tablet; Oral Terazosin Hcl Eq 2mg Base Tablet; Oral Terazosin Hcl Eq 5mg Base Tablet; Oral Terazosin Hcl Eq 5mg Base Tablet; Oral Terazosin Hcl Eq 10mg Base Tablet; Oral Terazosin Hcl Eq 1mg Base Tablet; Oral Terazosin Hcl Eq 2mg Base Tablet; Oral Terazosin Hcl Eq 5mg Base Tablet; Oral NewDrugInformation |